US 11111270
Inhibitor of apoptosis protein (IAP) antagonists
granted A61KA61K38/00A61P
Quick answer
US patent 11111270 (Inhibitor of apoptosis protein (IAP) antagonists) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
- Grant date
- Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P1/04